Kiyoshi Minegishi

High throughput screening of 16 million serologically negative blood donors for hepatitis B virus, hepatitis C virus and human immunodeficiency virus type-1 by nucleic acid amplification testing with specific and sensitive multiplex reagent in Japan

Hideko Mine, Hiroyuki Emura, Masaki Miyamoto et al. · Journal of Virological Methods · 2003 · 103 citations

Medicine, Infectious Diseases, Molecular Biology +15

Hepatitis B NAT virus‐positive blood donors in the early and late stages of HBV infection: analyses of the window period and kinetics of HBV DNA

Akira Yoshikawa, Yuhko Gotanda, Masako Itabashi et al. · Vox Sanguinis · 2005 · 90 citations

Medicine, Infectious Diseases, Microbiology +17

Prevalence of Anti‐HCV Antibody in Blood Donors in the Tokyo Area

Junnosuke Watanabe, Kiyoshi Minegishi, Tomoko Mitsumori et al. · Vox Sanguinis · 1990 · 81 citations

Medicine, Infectious Diseases, Preventive Medicine +16

Lengths of hepatitis B viremia and antigenemia in blood donors: preliminary evidence of occult (hepatitis B surface antigen–negative) infection in the acute stage

Akira Yoshikawa, Yuko Gotanda, Kiyoshi Minegishi et al. · Transfusion · 2007 · 68 citations

Medicine, Infectious Diseases, Microbiology +16

Superiority of minipool nucleic acid amplification technology for hepatitis B virus over chemiluminescence immunoassay for hepatitis B surface antigen screening

Kiyoshi Minegishi, Akira Yoshikawa, S Kishimoto et al. · Vox Sanguinis · 2003 · 48 citations

Medicine, Biotechnology, Infectious Diseases +17